Search - tctmd.com

Displaying 121 - 140 of 198

Sort: Relevancy | Date

Presentation TVT 2021

Valve-in-Valve TAVR vs Reoperative SAVR in Patients With Failed Aortic Bioprosthesis: Insight from Nationwide Readmission Database

Presenter: Ankur Kalra

July 22, 2021

Presentation TVT 2021

TAVR in TAVR in SAVR in a 26-Year-Old Girl

Presenter: Rikard Linder

July 21, 2021

Presentation TVT 2021

Comparative Analyses of PPM With SAVR and TAVR

Presenter: Neal Kleiman

July 20, 2021

Presentation TVT 2021

TAVR and SAVR “Sequencing”: Lifelong Management Journey of Severe AS

Presenter: Isaac George

July 20, 2021

Presentation

In-hospital Outcomes and Readmissions forValve-in-Valve TAVR vs Surgical Redo

June 01, 2020

Presentation Live Valves 2019

Failed Aortic Valve Bioprostheses: Valve-in-Valve or Redo-SAVR?

Presenter: Danny Dvir

December 10, 2019

Presentation Live Valves 2019

TAVI: Which Prosthesis for Which Patient?

Presenter: Holger Thiele

December 10, 2019

Presentation Live Valves 2019

Optimal hemodynamics: TAVI or SAVR?

Presenter: Lars Sondergaard

December 10, 2019

Presentation Live Valves 2019

Valve Guidelines: How Effective are They?

Presenter: Volkmar Falk

December 10, 2019

Presentation Live Valves 2019

Minimally Invasive Valve Surgery: Why Wait and How

Presenter: Marco Di Eusanio

December 10, 2019

Presentation Controversies and Advances 2019

Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial?

Presenter: Raj R. Makkar

November 15, 2019

Presentation TVT 2019

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

Presenter: Vinayak Bapat

June 13, 2019

Presentation EuroPCR 2019

Prosthetic valve endocarditis after transcatheter or surgical AVR with a bioprosthesis Results from the FinnValve registry

Presenter: Noriaki Moriyama

May 21, 2019

Presentation SIF 2019

My Prediction on TAVR in Low Risk Patients

Presenter: Kendra J. Grubb

March 30, 2019

Presentation SIF 2019

TAVR for Aortic Insufficiency

Presenter: Steven J Yakubov

March 30, 2019

Presentation CIT 2019

Status of indication of TAVR versus SAVR in low-intermediate risk patients

Presenter: Thomas Modine

March 28, 2019

Presentation ACC 2019

Primary Results From the Evolut Low Risk Trial

Presenter: Michael J. Reardon

March 17, 2019

Presentation JIM 2019

When and how to perform valvuloplasty: Experience with Valver

Presenter: Nicola Corcione

February 15, 2019

Presentation

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

February 06, 2019

Advertisement

Valve-in-Valve TAVR vs Reoperative SAVR in Patients With Failed Aortic Bioprosthesis: Insight from Nationwide Readmission Database

TAVR in TAVR in SAVR in a 26-Year-Old Girl

Comparative Analyses of PPM With SAVR and TAVR

TAVR and SAVR “Sequencing”: Lifelong Management Journey of Severe AS

In-hospital Outcomes and Readmissions forValve-in-Valve TAVR vs Surgical Redo

Failed Aortic Valve Bioprostheses: Valve-in-Valve or Redo-SAVR?

TAVI: Which Prosthesis for Which Patient?

Optimal hemodynamics: TAVI or SAVR?

Valve Guidelines: How Effective are They?

Minimally Invasive Valve Surgery: Why Wait and How

Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial?

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

Prosthetic valve endocarditis after transcatheter or surgical AVR with a bioprosthesis Results from the FinnValve registry

My Prediction on TAVR in Low Risk Patients

TAVR for Aortic Insufficiency

Status of indication of TAVR versus SAVR in low-intermediate risk patients

Primary Results From the Evolut Low Risk Trial

When and how to perform valvuloplasty: Experience with Valver

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content